{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-26-000475","form_type":"8-K","ticker":"ARTL","cik":"0001621221","company_name":"ARTELO BIOSCIENCES, INC.","filed_at":"2026-03-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.662447+00:00","generated_at":"2026-05-15T09:52:45.086914+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Artelo Biosciences raises $310k via 12% bridge notes with default conversion feature","bullets":["Issued two 12% bridge notes totaling $350,300 principal ($237,300 Vanquish + $113,000 Boot) for net proceeds of $310,000 after $40,300 OID.","Notes mature Jan 15, 2027; company may prepay at any time with no penalty.","Upon default, notes can convert into common shares at the higher of $0.125 or 75% of the 10-day VWAP; conversion capped at 4.99% beneficial ownership per holder.","Proceeds used for general working capital; Company reimbursed Vanquish $10,000 in fees.","Securities issued under Regulation D, Section 4(a)(2); represented as accredited investors only."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-26-000475","json":"https://secwatch.observer/filing/0001640334-26-000475.json","markdown":"https://secwatch.observer/filing/0001640334-26-000475.md","text":"https://secwatch.observer/filing/0001640334-26-000475.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000475/0001640334-26-000475-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000475/artl_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T09:52:45.086914+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"257cd320d137e422b59ad1392c71264832da6e30","claim":"ARTELO BIOSCIENCES, INC. entered into Vanquish Purchase Agreement with Vanquish Funding Group Inc. valued at $210,000.00 (effective 2026-03-12).","evidence_excerpt":"On March 12, 2026, Artelo Biosciences, Inc. (the “Company”) entered into a Securities Purchase Agreement, dated as of March 12, 2026 (the “Vanquish Purchase Agreement”), with Vanquish Funding Group Inc., a Virginia corporation (“Vanquish”), pursuant to which the Company issued a 12% bridge note in the aggregate principal amount of $237,300.00, which includes an original issue discount of $27,300.00, for an aggregate purchase price of $210,000.00 (the “Vanquish Note”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000475/0001640334-26-000475-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Vanquish Funding Group Inc."},{"label":"Value","value":"$210,000.00"},{"label":"Effective","value":"2026-03-12"}]},{"claim_id":"ef5a1775b2300aa961507c84543095ff77e9e82f","claim":"ARTELO BIOSCIENCES, INC. entered into Boot Purchase Agreement with Boot Capital LLC valued at $100,000.00 (effective 2026-03-12).","evidence_excerpt":"Additionally, on March 12, 2026, the Company entered into a Securities Purchase Agreement, dated as of March 12, 2026 (the “Boot Purchase Agreement” and together with the Vanquish Purchase Agreement, the “Purchase Agreements”), with Boot Capital LLC, a Delaware limited liability company (“Boot” and together with Vanquish , the “Buyers”), pursuant to which the Company issued a 12% bridge note in the aggregate principal amount of $113,000.00, which includes an original issue discount of $13,000.00, for an aggregate purchase price of $100,000.00 (the “Boot Note” and together with the Vanquish Note, the “Notes”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1621221/000164033426000475/0001640334-26-000475-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Boot Capital LLC"},{"label":"Value","value":"$100,000.00"},{"label":"Effective","value":"2026-03-12"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}